Skip to content

Clinical trials

Phase 3 Neoplasms by Site trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Phase: Phase 3 Country / region: Belgium Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20142
20151
20162
20182
20191
20201
20212
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting3
Terminated3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Hoffmann-La Roche2
Sumitomo Pharma America, Inc.2
Abbott1
Celgene1
Daiichi Sankyo1
Eli Lilly and Company1
Karyopharm Therapeutics Inc1
Novartis Pharmaceuticals1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms by Site15
Neoplasms14
Digestive System Diseases6
Digestive System Neoplasms6
Adenocarcinoma4
Breast Diseases4
Breast Neoplasms4
Carcinoma4
Neoplasm Metastasis4
Neoplasms by Histologic Type4

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.